Tower Research Capital LLC (Trc) Biora Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 10, 2023	BUY	$0.13 - $12.03 $6,553 - $606,456	50,412 Added 476.12%	61,000 $8,000
Q3 2022 Nov 10, 2022	BUY	$0.53 - $13.3 $662 - $16,625	1,250 Added 13.39%	10,588 $5,000
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.22 $15,761 - $34,338	-28,146 Reduced 75.09%	9,338 $7,000
Q1 2022 May 12, 2022	BUY	$1.11 - $2.25 $26,102 - $52,911	23,516 Added 168.36%	37,484 $44,000
Q4 2021 Feb 14, 2022	SELL	$1.35 - $4.89 $2,290 - $8,298	-1,697 Reduced 10.83%	13,968 $29,000
Q3 2021 Nov 15, 2021	BUY	$0.67 - $3.41 $2,201 - $11,205	3,286 Added 26.54%	15,665 $24,000
Q2 2021 Aug 16, 2021	BUY	$2.11 - $4.93 $8,009 - $18,714	3,796 Added 44.23%	12,379 $44,000
Q1 2021 May 17, 2021	SELL	$3.91 - $7.31 $19,420 - $36,308	-4,967 Reduced 36.66%	8,583 $41,000
Q4 2020 Feb 16, 2021	BUY	$3.27 - $9.48 $42,186 - $122,301	12,901 Added 1987.83%	13,550 $72,000
Q3 2020 Nov 16, 2020	BUY	$7.71 - $10.79 $5,003 - $7,002	649 New	649 $6,000

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $41.1M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.